XNCR
Xencor Inc
NASDAQ · Biotechnology
$11.61
+0.79 (+7.30%)
Open$11.14
Previous Close$10.82
Day High$11.65
Day Low$11.01
52W High$18.69
52W Low$6.92
Volume—
Avg Volume524.1K
Market Cap911.31M
P/E Ratio—
EPS$-1.88
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+113.4% upside
Current
$11.61
$11.61
Target
$24.77
$24.77
$14.60
$24.77 avg
$27.54
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 133.35M | 180.73M | 231.54M |
| Net Income | -280,733,131 | -342,450,281 | -11,326,541 |
| Profit Margin | -210.5% | -200.0% | -4.9% |
| EBITDA | -225,292,949 | -290,089,863 | -15,943,249 |
| Free Cash Flow | — | — | -7,053,340 |
| Rev Growth | -26.2% | -26.2% | -3.4% |
| Debt/Equity | 0.24 | 0.24 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |